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Background: The extracellular matrix (ECM) influences the structure, viability and functions of cells and tissues.
Recent evidence indicates that tumor cells and stromal cells interact through direct cell-cell contact, the production
of ECM components and the secretion of growth factors. Syndecans are a family of transmembrane heparan sulfate
proteoglycans that are involved in cell adhesion, motility, proliferation and differentiation. Syndecan-2 has been
found to be highly expressed in colorectal cancer cell lines and appears to be critical for cancer cell behavior. We
have examined the effect of stromal fibroblast-produced ECM on the production of proteoglycans by colorectal
cancer cell lines.
Results: Our results showed that in a highly metastatic colorectal cancer cell line, HCT-116, syndecan-2
expression is enhanced by fibroblast ECM, while the expression of other syndecans decreased. Of the various
components of the stromal ECM, fibronectin was the most important in stimulating the increase in syndecan-2
expression. The co-localization of syndecan-2 and fibronectin suggests that these two molecules are involved in
the adhesion of HCT-116 cells to the ECM. Additionally, we demonstrated an increase in the expression of
integrins alpha-2 and beta-1, in addition to an increase in the expression of phospho-FAK in the presence of
fibroblast ECM. Furthermore, blocking syndecan-2 with a specific antibody resulted in a decrease in cell adhesion,
migration, and organization of actin filaments.
Conclusions: Overall, these results show that interactions between cancer cells and stromal ECM proteins induce
significant changes in the behavior of cancer cells. In particular, a shift from the expression of anti-tumorigenic
syndecans to the tumorigenic syndecan-2 may have implications in the migratory behavior of highly metastatic
tumor cells.
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The extracellular matrix (ECM) is an extremely complex
supramolecular structure that is locally secreted by cells
and influences the structure, viability and functions of cells
and tissues. Epithelial-mesenchymal and epithelial-stromal
interactions play important roles in both physiological and
pathological settings, such as during embryonic morpho-
genesis [1,2], wound healing [3] and tumorigenesis [4],
and are accompanied by dynamic changes that generate
new cell-matrix interactions [5]. Cell contact with a single* Correspondence: ltoma.bioq@gmail.com
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reproduction in any medium, provided the orECM component initiates multiple signals that affect both
cell behavior and gene expression [6,7].
The tumor microenvironment plays an important role in
the behavior of malignant cells. The functional association
of cancer cells with surrounding tissues changes as the ma-
lignancy progresses and is accompanied by the remodeling
of the ECM [8]. A severe fibrotic reaction around tumor
tissues represents a host reaction to tumor growth. Fibro-
blasts are the main source of fibrotic tissue, which consists
mainly of collagen types I and IV. In addition to collagen,
several other ECM proteins are present, including fibro-
nectin, laminin, tenascin and proteoglycans [9]. Increasing
evidence has demonstrated the involvement of cell surface
proteoglycans in the multi-functional network of cell-cellLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tumor invasion and subsequent metastasis [10-13].
Syndecan-2 is one of the four members of the syndecan
family of cell surface transmembrane heparan sulfate (HS)
proteoglycans. It has been implicated in the formation of
specialized membrane domains and functions as a direct
link between the extracellular environment and the
organization of the cortical cytoplasm. In several colorec-
tal cancer cell lines, syndecan-2 is highly expressed com-
pared to normal cell lines [14-16]. This increase appears
to be critical for cancer cell behavior because it regulates
adhesion and proliferation and, therefore, tumorigenic ac-
tivity [17]. In order to examine the relationship between
tumor cells and stromal fibroblasts, we used an in vitro
model to investigate the effect of ECM that is produced by
stromal fibroblasts on the synthesis of glycosaminoglycans
(GAGs) and proteoglycans by two colorectal cancer cell
lines, Caco-2 and HCT-116, which have different meta-
static potentials.
Results
Stromal fibroblast ECM influences GAG synthesis by
HCT-116 colorectal cancer cells
To analyze the interactions between tumor cells and stro-
mal fibroblast ECM, two colorectal cancer cell lines with
different metastatic potentials, Caco-2 and HCT-116 cells,
were studied. The influence of stromal fibroblast-produced
ECM on GAG and proteoglycan synthesis by the cancer
cells was investigated.
Tumor cells were cultured for three days on top of
stromal ECM and then labeled with [35S]Na2SO4. The
GAGs synthesized were analyzed by agarose gel electro-
phoresis in 0.05-M 1,3-diaminepropane acetate buffer
and quantified as described in the Methods.
The Caco-2 colorectal cancer cell line, which has low
metastatic potential, produces both chondroitin sulfate
(CS) and HS, the former being more abundant in the
medium and the latter being more abundant in cell ex-
tracts (Figure 1). There was no difference in GAG synthe-
sis by Caco-2 cells in the presence or absence of stromal
fibroblast ECM. In the HCT-116 colorectal cell line, which
has high metastatic potential, the same GAG distribution
profile was observed, but there was a significant increase
in medium, cell extract and matrix HS production when
cells were cultured on top of stromal ECM (Figure 1).
Gene expression of surface and ECM proteoglycans is
modulated by stromal fibroblast ECM
Proteoglycan expression was analyzed to confirm the GAG
synthesis results. We investigated the expression of the
family of syndecans (-1, -2, -3 and -4), which have been
shown to be involved in cancer-stroma interactions [15,18].
Stromal fibroblast ECM did not significantly affect the
expression of syndecans in Caco-2 cells, with theexception of syndecan-2, which decreased in the presence
of stromal fibroblast ECM (Figure 2). Many colon cancer
cell lines show increased syndecan-2 expression, and this
up-regulation seems to be crucial for their tumorigenic ac-
tivity. In contrast, colon cancer cell lines HT29, Caco-2
and DLD1 show low syndecan-2 expression, and inhib-
ition of syndecan-2 function in these cell lines did not
affect any of their adhesion, proliferation, invasion and mi-
gration [15].
In opposition, stromal fibroblast ECM decreased
syndecan-1, -3 and -4 expression, but significantly in-
creased syndecan-2 expression in HCT-116 cells (Figure 2).
Of the four syndecan family members, syndecan-2 has
been previously reported as up-regulated in several colon
carcinoma cells and, further, that this increased expression
is crucial for tumorigenicity [19,20].
Stromal fibroblast ECM influences the synthesis of
syndecan-2 by HCT-116 colorectal cancer cells
To confirm the increase in HCT-116 syndecan-2 expres-
sion that was induced by stromal fibroblast ECM at the
protein level, and to relate it with GAGs synthesis, the cells
were labeled with [35S]sulfate and immunoprecipitated with
an antibody against the extracellular domain of human
syndecan-2 proteoglycan (Figure 3A). The results clearly in-
dicate that the stromal fibroblast increases the amount of
syndecan-2 in HCT-116 cells (Figure 3B). Furthermore, the
results show the association of HS augments with this
syndecan isoform. Through western blotting, a 150% in-
crease of syndecan-2 in HCT-116 cells cultured in the pres-
ence of stromal fibroblasts ECM was observed therefore
corroborating the immunoprecipitation (Figure 3C and D).
We also detected cell surface syndecan-2 levels by flow
cytometry. HCT-116 cells were cultured for three days
in the presence or absence of stromal fibroblast ECM.
As a control, cells were cultured in the presence of their
own ECM. Significant levels of cell surface syndecan-2
were detected by flow cytometry when cells were grown
on fibroblast ECM but not on their own ECM
(Figure 4A). An increase in the expression of syndecan-2
as observed (Figure 4B).
We next investigated which specific component of the
ECM was responsible for stimulating the increase in
syndecan-2 expression. Initially, fibroblasts were immuno-
stained with anti-fibronectin, anti-laminin or anti-collagen
to confirm their presence in the ECM (Figure 4C). The
expression of fibronectin was also confirmed through
Western blotting, however collagen and laminin were not
detected on ECM produced by fibroblasts through this
method (Fgure 4D). Flow cytometry was then performed
on HCT-116 cells grown in culture dishes coated with fi-
bronectin, laminin or collagen type I for three days
(Figure 4E). Laminin and collagen type I did not increase
syndecan-2 expression on HCT-116 cells over control
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syndecan-2 expression (Figure 4F).
To further investigate this fibronectin-induced increase
in syndecan-2 expression, HCT-116 cells were cultured in
the presence of fibronectin for different lengths of time
(Figure 4G). Surprisingly, short incubation (12 h and 24 h)
with fibronectin led to a remarkable increase in syndecan-
2 expression (Figure 4H). Overall, our results show thatFigure 1 Effect of stromal fibroblast ECM on the synthesis of GAGs b
(Ctrl) or presence (Fibrob. ECM) of stromal fibroblast ECM. GAGs were labeled
cancer cells (CELL) and the matrix (MATRIX) produced by Caco-2 or HCT-116 c
agarose gel electrophoresis in 1,3-diaminepropane acetate buffer (0.05-M pH
using an image analysis system, the Cyclone® Storage Phosphor System-Packa
Opti-Quanti Software. Heparan sulfate (HS), chondroitin sulfate (CS). *p ≤ 0.05stromal ECM induces the expression and synthesis of
syndecan-2 in HCT-116 colorectal cancer cells and that
the fibronectin component of ECM is mainly responsible
for this effect.
Taking into account the influence of fibronectin in the
expression of syndecan-2, we analyzed the co-localization
of these molecules through immunocytochemistry. Caco-2
cells presented no staining for syndecan-2, even in they Caco-2 and HCT-116 cells. Cancer cells were cultured in the absence
with [35S]Na2SO4 and were purified from the culture medium (MEDIUM),
ells. (A) The content of GAGs from these compartments was analyzed by
9.0). The gel was exposed to a screen and the bands were identified
rd Instrument. (B) Quantification was performed by densitometry with
compared to control.
Figure 2 Effect of stromal fibroblast ECM on the expression of syndecans in Caco-2 and HCT-116 cells. Caco-2 (A) and HCT-116 cells
(B) were cultured on Petri dishes in the absence (Ctrl) or presence of fibroblast ECM (Fibrob. ECM) for three days, and RNA was extracted. The
expression level of each gene was normalized to that of β-actin. The data from each experiment were obtained in triplicate and are represented
as the average ± standard deviation. *p ≤ 0.05. Syndecan-1 (Syn-1), syndecan-2 (Syn-2), syndecan-3 (Syn-3), syndecan-4 (Syn-4).
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and there was a slight increase in the staining of fibronec-
tin, probably due to protein produced by the fibroblasts
(Figure 5E). On the other hand, a strong staining for
syndecan-2 was observed at the HCT-116 cells, especially
in the presence of stromal fibroblasts ECM (Figure 5C and
F), and co-localized with fibronectin, which confirms our
previous results (Figure 5D).
Syndecan-2 participates in the cell adhesion, migration
and organization of actin filaments in HCT-116 cells
Interactions between ECM molecules and cell surface
receptors, such as heparan sulfate proteoglycans and
integrins, can modulate the organization of the cytoskel-
eton. Therefore, we examined whether stromal fibroblast
ECM regulated the organization of actin filaments in
HCT-116 cells. Cells that were cultured on fibroblast ECM
showed a higher organization of cortical actin filaments,
indicating reorganization of the cytoskeleton (Figure 6).
We next investigated whether syndecan-2 played a role
in cell adhesion, migration and actin filament formation.
HCT-116 cells, previously grown on top of fibroblasts
ECM, were pre-incubated with an anti-syndecan-2
blocking antibody and then plated on stromal fibroblast
ECM for different lengths of time. Cells that were pre-
treated with anti-syndecan-2 remained isolated and did
not aggregate like normal cells in this cell line. In con-
trol cells that were pre-incubated with control IgG or no
antibodies, a higher organization of actin filaments was
observed over time, as well as the formation of plasma
membrane extensions that are indicative of stress fibers.
Cells that were pre-treated with anti-syndecan-2 blocking
antibody did not form stress fibers and remained round
with cortical actin (Figure 7). Moreover, they were less ad-
herent to the ECM (Figure 8A).Previous studies have implicated syndecan-2 in HCT-
116 cell motility [16,20]. To investigate this hypothesis,
transmigration assays were performed. HCT-116 cells
were pre-incubated with anti-syndecan-2, human IgG or
no antibodies, seeded on transwell membranes coated
with stromal fibroblast ECM and allowed to migrate for
24 h. Migratory cells on the bottom chamber of the
transwell were counted with an inverted microscope.
Cells in which syndecan-2 was blocked did not migrate
through the transwell membrane (Figure 8B).
To further investigate the mechanisms involved in the
increment of cell adhesion, we analyzed the expression
of integrins through flow cytometry. Or results showed a
three fold increase in the expression of integrins alpha-2
and beta-1 (Figure 9A and B), in addition to an increase
in the expression of phospho-FAK.
The increase in phosphorylation of FAK and Src has
been correlated to metastatic potential of different cancers.
Src family kinase and FAK activity are required for cell ad-
hesion, spread and migration. Therefore, the signaling
pathways were analyzed primarily through western blotting
of cell extracts. Quantitative densitometry enabled the
quantification of the levels of SrcY416, FAKY397 as well as of
their phosphorylated form, thereby, determining the level
of activation of the signaling pathways. HCT-116 cells that
were cultured on fibroblast ECM showed an increase in
phosphorylation of FAK and Src (Figure 9C and D).Discussion
The cross-talk between cells and the ECM involves in-
teractions between the individual components of the
ECM and their respective receptors on the cell surface.
Cell contact with ECM components initiates multiple
signals that affect both cell behavior and gene expression
Figure 3 Expression of syndecan-2 in HCT-116 cells. (A) Immunoprecipitation of syndecan-2 from HCT-116 cells in the absence of matrix (Ctrl) or
in the presence of stromal fibroblast ECM (Fibrob. ECM). HCT-116 cells were cultured for 72h and exposed to [35S]sulfate for 24 h, and the radioactive
proteoglycans were extracted as described in Methods. The proteoglycans from the cells were immunoprecipitated with anti-syndecan-2 antibody and
were then applied to the gel. (B) Quantification of the experiment shown in A. (C) HCT-116 cells were seeded on stromal fibroblast ECM and cultured
for three days. Lysate proteins were separated on 10% SDS-PAGE and electro-transferred to PVDF membrane. Membranes were blocked and incubated
using anti-syndecan-2 (Syn-2) and anti-β-actin (loading control). Antibody binding was visualized by chemiluminescence and the relative levels of
these proteins were determined by densitometric analysis (D). *p ≤ 0.05 compared to control.
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influenced by cell adhesion to the ECM. In our previous
work, we demonstrated that tumor cells and stromal
cells communicate through an amalgam of secreted sol-
uble factors [8]. Fibroblast and prostate tumor cell
cross-talk lead to fibroblast differentiation, TGF-β, and
extracellular matrix down-regulation. In this study, we
found that stromal fibroblast ECM significantly in-
creased the cell adhesion, migration and organization of
actin filaments in colorectal cancer cells.
Our results suggest that stromal ECM influences the
amount of GAGs on tumor cells, leading to an increase in
HS produced by HCT-116 cancer cells. HS proteoglycans,
which are composed of a core protein and HS chains, are
prevalent on the cell surface and basement membrane and
have been shown to regulate various cell behaviors [21].
Syndecans are a family of transmembrane HS proteoglycansthat bind ECM molecules and/or soluble ligands and
transduce signals that influence cell adhesion, motility,
proliferation, differentiation and morphogenesis [22-24].
The HS proteoglycan-ECM interaction is differentially
regulated in cancerous versus normal cells because cancer
cells are less adhesive and more migratory compared to
normal cells [25].
This study showed that syndecan-2 mRNA expression
in a highly metastatic colorectal cancer cell line, HCT-
116, is enhanced when the cancer cells were cultured in
the presence of ECM that was produced by fibroblasts.
The augment of syndecan-2 was also visualized by im-
munoprecipitation with anti-syndecan-2 antibody. In
contrast, the expression of syndecans-1 -3 and -4
decreased. Increased syndecan-2 expression has been
reported in several colorectal cancer cell lines with a
concomitant decrease in syndecans-1 and -4 [15,16].
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sion, and inhibition of syndecan-2 function in this cell line
did not affect any of their adhesion, proliferation, invasion
and migration [15]. Although derived from a colon (large
intestine) carcinoma, when cultured under specific condi-
tions the cells become differentiated and polarized suchFigure 4 Flow cytometric analysis of syndecan-2 surface expression o
absence of matrix (Ctrl), in the presence of stromal fibroblast ECM (Fibrob
then immunostained with anti-syndecan-2 antibody. (B) The relative stain
immunostained with anti-fibronectin antibody, anti-laminin antibody or a
photo shows images that were obtained using a confocal microscope. HC
I and labeled with anti-syndecan-2 antibody. (D) Fibroblasts were cultured
described in Methods. Total protein from the ECM (Fibro. ECM) was then
(P). After transfer, the nitrocellulose membrane was incubated with anti-fi
detected on ECM produced by fibroblasts through Western blotting. (E) H
fibronectin for 72 h and then stained with anti-syndecan-2 antibody and
analysis (F). (G) HCT-116 cells were cultured in the absence or presence o
then stained with anti-syndecan-2 antibody and the relative staining was
the control cells cultured in the absence of ECM, the black line represents
the control for the secondary antibody, anti-IgG. *p ≤ 0.05 compared to cthat their phenotype, morphologically and functionally, re-
sembles the enterocytes lining the small intestine [26].
Syndecan-1 has been associated with tumor suppressor
function, and its expression is downregulated in a variety
of cancer tissues. Similarly, syndecan-4, which is mainly
involved in cytoskeletal and membrane reorganizationn HCT-116 cells. (A) HCT-116 cells were cultured for 48 h in the
. ECM) or in the presence of their own matrix (HCT-116 self ECM) and
ing was determined by densitometric analysis. (C) Fibroblasts were
nti-collagen antibody to confirm the presence of these proteins. The
T-116 cells were cultured for 72 h on fibronectin, laminin or collagen
in Petri dishes until confluence and its ECM was extracted as
applied to polyacrylamide gel 7.5% with 10μg of standard fibronectin
bronectin and revealed with DAB. Collagen and laminin were not
CT-116 cells were cultured in the presence of collagen-I, laminin or
the relative levels of this protein were determined by densitometric
f fibronectin for different lengths of time (12, 24, 48 and 72 h) and
determined by densitometric analysis (H). The gray peak represents
cells cultured in the presence of ECM and the gray line represents
ontrol.
Figure 5 Co-localization of syndecan-2 and fibronectin on Caco-2 and HCT-116 cells. (A) Caco-2 cells were cultured on Petri dishes in the
absence(Ctrl) or (B) presence of fibroblast ECM (Fibro. ECM) for three days. (C) HCT-116 cells were cultured on Petri dishes in the absence (Ctrl) or
(D) presence of fibroblast ECM (Fibrob. ECM) for three days. Cells were immunestained with anti-fibronectin (III, green) and anti-syndecan-2
(I, red). The nuclei (II, blue) were stained with DAPI. Immunofluorescent images were captured using confocal microscopy. Co-localization of
images (IV, Merge). Scale bar represents 20 μm. The relative fluorescence levels of proteins were determined by densiometric analysis and
represented as a percentage of controls (E and F). *p ≤ 0.05 compared to control.
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later stages of fibroblast spreading, inhibits cell migra-
tion and tumor activity [13]. Consistent with this, the
mRNA expression levels of syndecan-1 and -4 are sig-
nificantly reduced in several cancer cells, including
colon carcinoma cells.
On the other hand, syndecan-2 is involved in the regula-
tion of cell adhesion in several cell lines, including epithe-
lial cells, and several reports indicate that syndecan-2 is
normally highly expressed in cells under migratory condi-
tions [17]. These reports also indicate that syndecan-2
may function as a cell surface receptor in highly migratory
tumor cells. In several colorectal cancer cell lines,
syndecan-2 is highly expressed compared to normal cell
lines. This increase appears to be critical for cancer cell
behavior because it regulates adhesion and proliferation
and, therefore, tumorigenic activity. This implies that dur-
ing malignant transformation, there is a shift from the ex-
pression of anti-tumorigenic syndecans (-1 and -4) to the
tumorigenic syndecan-2 [27].HS proteoglycans are well known to interact with spe-
cific ECM proteins [28]. Fibronectin contains two binding
sites for heparin, named Hep-I and Hep-II in the N- and
C-terminal domains, respectively [29,30], and provides
structural support for cell adhesion. Fibronectin also par-
ticipates in the transduction of signals that promote actin
dynamics, migration and cell proliferation. Our results
showed that fibronectin is mainly responsible for the in-
creased expression and synthesis of syndecan-2 in HCT-
116 colorectal cancer cells that was induced by stromal
fibroblast ECM. We also observed co-localization of
syndecan-2 and fibronectin by confocal microscopy.
Therefore, in addition to binding to syndecan-2, fibronec-
tin is also able to regulate its expression.
Furthermore, blocking syndecan-2 with a specific anti-
body resulted in a decrease in cell adhesion and migra-
tion, as well as the decreased organization of actin
filaments during cell adhesion, highlighting an important
role for syndecan-2 in the regulation of actin filaments.
The cytoplasmic domain of syndecan-2 interacts with
Figure 6 Distribution of actin filaments in HCT-116 cells. Cells were cultured in Petri dishes containing glass coverslips in the absence
(A) or presence (B) of stromal fibroblast ECM. Actin filaments were stained with phalloidin conjugated to Alexa 488 (green). The cells were
counterstained with DAPI to detect the nucleus (blue). The photo above shows images that were obtained using confocal microscopy.
Scale mark: 20 μm.
Vicente et al. BMC Cell Biology 2013, 14:25 Page 8 of 14
http://www.biomedcentral.com/1471-2121/14/25Ezrin, Radixin and Moesin (ERM) family proteins, which
are involved in the organization of the actin cytoskeleton
and the activation of focal adhesion kinase [31-33].
Kusano and colleagues demonstrated that the induction of
stress fiber formation in Lewis lung carcinoma-derived
P29 cells during adhesion to fibronectin requires co-
operation between integrin α5β1 with cell surface
heparan sulfate from syndecan-2. Side chains with
dodecasaccharide(s) enriched in the disaccharide, IdoA
(2OS)–GlcNS(6OS), are necessary for the specific inter-
action between syndecan-2 and the C-terminal heparin-
binding domain of fibronectin [27].
In migratory cells, forced expression of syndecan-2 in-
duces filopodial extensions and results in rearrange of the
actin cytoskeleton [34]. Our results also show that
syndecan-2 is necessary for HCT-116 cells to migrate
through stromal ECM. This is consistent with previous
studies showing that syndecan-2 expression in colorectal
cancer-derived HT-29 M6 epithelial cells induces a migra-
tory phenotype [35] that is associated with noticeable
increases in cell proliferation, invasion and anchorage-
independent growth [14].
In addition to dramatic adhesion and migration changes,
the contact with stromal fibroblasts ECM increased
integrins alpha-2 and beta-1 expressed in HCT-116 cancer
cells. Choi and colleagues showed that overexpression of
syndecan-2 enhanced collagen adhesion, cell migration
and invasion of normal rat intestinal epithelial cells (RIE1),
and increased integrin alpha-2 expression levels. Interest-
ingly, RIE1 cells transfected with either syndecan-2 or
integrin alpha-2 showed similar adhesion and migration
patterns, and a function-blocking anti-integrin alpha-2
antibody abolished syndecan-2-mediated adhesion and
migration [19]. Moreover, syndecan-2 is crucial for the
tumorigenic activity of sarcoma cells and this function
relies on FAK-mediated signaling [36].FAK and Src are non-receptor tyrosine kinases that
control a number of cellular signaling pathways, includ-
ing cell motility and survival, and playing a pivotal role
in integrin-linked signal transduction, such as that asso-
ciated with cell migration [37]. In several cell types, FAK
directly recruits Src to the focal adhesion sites where Src
potentiates activation of FAK through phosphorylation
of additional tyrosine residues. Tyrosine phosphorylation
of FAK and integrin molecules creates docking sites for
other proteins involved in actin cytoskeleton remodeling.
High levels of FAK have been found in a variety of car-
cinomas, including head and neck carcinomas, ovarian
carcinomas, thyroid carcinomas, and colon carcinomas
[36].Our findings showed that the contact of colorectal
cancer cells with fibroblasts ECM resulted in increased
phosphorylation of FAK and Src. Therefore, our results
further reinforce the collaboration of syndecan-2 and
FAK in colorectal tumorigenesis.
In summary, the cell surface heparan sulfate proteogly-
can adhesion receptor, syndecan-2, plays a critical role in
regulating the tumorigenic activity of HCT-116 colorectal
cancer cells. It can be over-expressed by the contact of can-
cer cells with stromal ECM, specifically fibronectin, leading
to an increase in cell adhesion and migration, probably
through FAK-mediated signaling.
Conclusion
Our results demonstrate a role for stromal ECM in regu-
lating the expression of surface proteins in cancer cells,
which are able to transduce signals that ultimately affect
cell adhesion and morphology. The use of stromal fibro-
blast ECM alone allowed us to study its influence on the
synthesis of proteoglycans and GAGs by colorectal can-
cer cells. Although this model does not take into consid-
eration the cross-talk between tumor and stromal cells
via soluble proteins such as growth factors, contact with
Figure 7 Effect of syndecan-2 blockade on actin filament formation in HCT-116 cells. HCT-116 cells, previously grown on top of fibroblast
ECM for three days, were incubated with anti-syndecan-2 antibody (Anti-Syn-2), IgG (IgG) or no antibodies (Ctrl) and then plated on stromal
fibroblast ECM-coated glass coverslips for different lengths of time. Actin filaments were stained. The image above was obtained by fluorescence
microscopy. F-actin is labeled with phalloidin in green; nucleus is labeled with DAPI in blue. Scale mark: 20 μm.
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alterations in cancer cell behavior. The increase of
syndecan-2 expression in human colon cancer tissues has
already been demonstrated [14], and our results showed
that ECM proteins can be responsible for this augmenta-
tion. Therefore, although this is an in vitro study, we
attempted to model what occurs during tumorigenesis
in vivo, during which tumor cells are not isolated but
engage in cross-talk with cancer-associated stroma.
Methods
Cell culture
The colorectal adenocarcinoma cell line Caco-2 and the
colorectal carcinoma cell line HCT-116 were purchased
from ATCC (American Type Culture Collection, Manassas,
VA, USA). Human fibroblast cells primary isolated from
amniotic fluid were kindly donated by Dr. Walter Pinto
Júnior. These cells were properly characterized on our pre-
vious work, and the presences of fibroblasts markers, such
as vimentin, were confirmed [8]. HCT-116 cells were
grown in RPMI (GibcoBRL, Life Technologies Inc., Grand
Island, NY), medium supplemented with 10% (v/v) fetalbovine serum (FBS, Cultilab, Campinas, Brazil), penicillin
(100 units/ml) and streptomycin (100 μg/ml, Invitrogen) at
37°C in a humidified atmosphere of 5% CO2. Caco-2 cells
and fibroblasts were grown in Dulbecco’s modified Eagle’s
medium (DMEM, GibcoBRL) supplemented with 10% (v/v)
FBS, penicillin (100 units/ml) and streptomycin (100 μg/ml,
Invitrogen, Carlsbad, CA) at 37°C in a humidified atmos-
phere of 5% CO2.
Preparation of stromal ECM
Fibroblasts were plated in 35-mm Petri dishes (5×105
cells/ml medium, Corning Incorporated, Corning, NY)
and cultured for three days. The cells were then washed
with Earle’s balanced salt solution (EBSS) and incubated
in PBS containing 0.025% EDTA for 20 min to detach
cells while allowing the ECM to remain intact [38]. The
detached cells were aspirated, and the plates were gently
washed three times with EBSS and monitored by an op-
tical microscope to ensure that all cells were removed.
Colorectal cancer cells were then seeded on top of the
fibroblast ECM and cultured for three days. As a control,
we used cells cultured in the absence of fibroblast ECM.
Figure 8 Effect of syndecan-2 blockade on adhesion and migration of HCT-116 cells to stromal fibroblast ECM. (A) HCT-116 cells,
previously grown on top of fibroblast ECM for three days, were incubated with anti-syndecan-2 antibody (Anti-Syn-2), IgG (IgG) or no antibodies
(Fibrob. ECM) and then plated on stromal ECM-coated Petri dishes for different lengths of time. Non-adherent cells were removed, and adhesion
was measured by MTT colorimetric assay. The formazan crystals formed were solubilized with DMSO, and the absorbance was measured at 540
nm. (B) Transwell membranes (Costar, Corning, 8-μm pore size) were coated with stromal fibroblast ECM as described above. HCT-116 were
pre-incubated with anti-syndecan-2 antibody (Anti-Syn-2), IgG (IgG) or no antibodies (Ctrl) and plated in the top of chamber. Migrating cells were
fixed in formaldehyde, stained with crystal Violet, and counted. * p ≤ 0.05.
Vicente et al. BMC Cell Biology 2013, 14:25 Page 10 of 14
http://www.biomedcentral.com/1471-2121/14/25[35S]-Sulfate metabolic radiolabeling of GAGs
Caco-2 and HCT-116 cells were seeded on stromal
fibroblast ECM and cultured for three days. Cells were
then incubated with [35S]Na2SO4 (100 μCi/ml) for 24 h
for GAG labeling. The medium was removed, and the
cells were washed with PBS. The cells were then de-
tached with 0.025% EDTA, and the ECM that was
formed by these cells was extracted with 0.01% trypsin.
The cells were lysed by treatment with 3.5-M urea in
PBS. Proteoglycans from the medium, cell extract and
matrix were precipitated for 18 h at −20°C with 3 vol-
umes of ethanol in the presence of heparan sulfate as a
carrier. Ethanol pellets were dried and subjected to pro-
teolysis with maxatase, a protease from Sporobacillus,
(4-mg/ml) in 0.05-M Tris–HCl, pH 8.0 for 24 h at 60°C.
Labeled GAGs were dried and resuspended in 100 μl of
water. The composition of GAGs in each compartment
(medium, cell extract and matrix) was analyzed by agar-
ose gel electrophoresis.GAG analysis by agarose gel electrophoresis
Samples (5 μl) were applied to agarose gel slabs in 0.05-M
1,3-diaminepropane acetate buffer pH 9.0 [39,40]. Follow-
ing electrophoresis, GAGs were precipitated for 1 h with
0.2% cetyltrimethylammonium bromide. 35S-radiolabeled
GAGs were visualized after exposure to Cyclone™ Storage
Phosphor Screen (Packard Instrument Company Inc.,
Japan) for 24 h, and images were acquired using a Cyclone™
Storage Phosphor System (Packard Instrument Company
Inc., Japan). CS and HS were identified after agarose gel
electrophoresis, based on the difference in migration under
this electrophoresis condition, as previously described
[41,42]. Quantitative analysis was performed by densitom-
etry using the Opti-Quanti Software.
RNA extraction and real time PCR
Total RNA was extracted from cultured cells using
Trizol® reagent (Invitrogen) according to the manufac-
turer’s guidelines. The total RNA extracted was used as
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of cDNA were amplified using the following primers: hu-
man syndecan-1 (NM_001006946) forward (F): AGGGCT
CCTGCACTTACTTGCTTA and reverse (R): ATGTGCA
GTCATACACTCCAGGCA; human syndecan-2 (NM_00
2998) F: AACTTCTGCCGTAGCTCCCTTTCA and R: A
GGCTGCTCTCTGAAGCTCTTCTT; human syndecan-3
(NM_014654) F: AAGGAGGTGCTCGTAGCTGTGATT
and R: TCCTGCTTGTCAGGCTTCTGGTAT; humanFigure 9 Effect of stromal fibroblast ECM on the expression of integr
cells. (A) HCT-116 cells were cultured for 48 h in the absence of matrix (Ct
immunostained with anti-integrin-β1, anti-integrin-α2 or anti-phospho-FAK
staining was determined by densitometric analysis. (C) HCT-116 cells were
proteins were separated on 10% SDS-PAGE and electro-transferred to PVDF
anti-phospho-FAK, anti-Src, anti-phospho-Src and anti-β-actin (loading cont
relative levels of these proteins were determined by densitometric analysissyndecan-4 (NM_002999) F: CCAGTTTGATGTTGCTG
GGTGGTTand R: AGCCCTAGAGCCTGAAGAAAGCA
A; human β-actin (NM_001101) F: ACCAACTGGGACG
ACATGGAGAAA and R: TAGCACAGCCTGGATAGCA
ACGTA. After an initial denaturation step at 94°C for
5 min, the following steps were carried out for 35 cycles:
denaturation at 94°C for 30 s, annealing at 55°C for 30 s
and extension at 72°C for 60 s. The PCR products were ana-
lyzed on 1% agarose gels and sequenced to confirm theirins β1 and α2, and phosphorylation of FAK and Src in HCT-116
rl), in the presence of stromal fibroblast ECM (Fibrob. ECM) and then
. The staining was analyzed through flow cytometry. (B) The relative
seeded on stromal fibroblast ECM and cultured for 48 h. Lysate
membrane. Membranes were blocked and incubated using anti-FAK,
rol). Antibody binding was visualized by chemiluminescence and the
(D). *p ≤ 0.05 compared to control.
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SYBR® Green PCR Master Mix and AmpliTaq-GOLD poly-
merase (Applied Biosystems, Foster City, CA). Reactions
were performed on the ABI PRISM 7500 Real Time PCR
System (Applied Biosystems). Briefly, 1 μl of diluted cDNA
was added to SYBR® Green PCR Master Mix, and forward
and reverse primers were added to a final concentration of
0.5 μM. All reactions were performed in triplicate. PCR
cycling conditions were as follows: DNA denaturation for
10 min at 95°C and then 35 cycles of 95°C for 15 s, 60°C
for 1 min and 72°C for 30 s. Fluorescence data were
recorded at the end of each 72°C step. A DNA melting
profile was subsequently run from 72°C to 95°C with a
ramp of 1°C/5 s. Fluorescence data were recorded continu-
ously during the melt profile. The relative expression levels
of genes were calculated using the 2-ΔΔCT method [43].
The levels of target gene expression in each sample were
normalized to the average expression level of the endogen-
ous control, β-actin.
Immunoprecipitation of syndecan-2
Proteoglycans synthesized by the cells were metabolically
labeled with [35S]Na2SO4 (100 μCi/ml), as described above.
At the end of the incubation period, the culture medium
was removed and the cells were washed twice with PBS.
The cells were scrapped from the dish with a lysis buffer
containing 1% NP-40, 10% glycerol, 135 mM NaCl, 20 mM
Tris–HCl pH 8.0. Cell lysates containing equal amounts of
total protein were incubated with anti-syndecan-2 (1:50,
Santa Cruz Biotechnology, Santa Cruz, CA) at 4°C for
2 hours. The lysates were then incubated with 50 μl of a
suspension of protein A-sepharose beads in PBS (1:1, wt/v)
at 4°C for 1 h. The beads were pelleted by centrifugation,
washed with 3 × 1 ml of the lysis buffer, 2 × 1 ml of 20 mM
Tris–HCl pH 8.0 containing 1 M LiCl and 2 × 1 ml of
20 mM Tris–HCl pH 8.0. All solutions contained protease
inhibitors (1 mM phenylmethylsulfonyl fluoride, 10 mM
N-ethylmaleimide, 10 mM EDTA). The proteoglycans were
identified by agarose gel electrophoresis as previously
described [41,42].
Protein preparation and western blotting
For the extraction of proteins, HCT-116 cells were seeded
on stromal fibroblast ECM and cultured for three days.
Adhered cells were removed from the culture dishes with
the aid of a cell scrapper in cell lysis buffer (Cell Signaling,
MA, USA) containing proteinase inhibitor cocktail
(Roche, Mannheim, Germany) and, thereafter, exposed to
10 freeze/thaw cycles. For the extraction of proteins from
fibroblasts ECM, the cells were detached with 0.025%
EDTA, and the remaining ECM was removed from the
culture dishes with the aid of a cell scrapper. The total
protein content of the cell extracts was measured using
the Micro BCA Protein Assay Kit (Pierce, Rockford, IL).The lysate proteins were separated according to molecular
mass by sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE) using a 10% polyacrylamide gel
(Merck, Whitehouse Station, NJ) and transferred to
polyvinylidene difluoride membranes (Millipore, Bedford,
MA, USA) by 2.5 h electroblotting at 200 mA constant
current in blotting buffer (20 mM Tris-base, 150 mM gly-
cine, 20% methanol) using a Mini Trans-Blot Electrophor-
etic Transfer Cell (Bio-Rad Laboratories). The membranes
were quenched for 1 h with 5% non-fat dry milk in TBST
buffer (200 mM Tris/HCl buffer, pH 8.0 containing 150
mM NaCl and 0.05% Tween-20) and then incubated over-
night at 4°C with primary antibodies: rabbit anti-syndecan-
2 (Santa Cruz), goat polyclonal anti-fibronectin (Santa
Cruz), goat anti-laminin (Santa Cruz),rabbit anti-collagen-I
(Pierce), rabbit anti-phospho-Src (Y416) (Cell Signaling),
rabbit anti-Src (Cell Signaling), rabbit anti-phospho-FAK
(Y397) (Cell Signaling), rabbit anti-FAK (Cell Signaling),
mouse anti-integrin β1 (Santa Cruz), goat anti-integrin α2
(Santa Cruz) and anti-β-actin (Sigma Chemical Company,
St. Louis, MO), diluted in 1% bovine serum albumin (BSA)
in TBST. Thereafter, the membranes were further incu-
bated for 1 h at room temperature with the appropriate
secondary antibodies conjugated with Horseradish peroxid-
ase (Cell Signaling) diluted in 1% BSA in TBST. After each
step, membranes were sequentially washed three times with
TBST. Chemiluminescence signal detection was performed
using the gel documentation system G:Box Chemi HR16
(Syngene, Frederick, MD, USA). Densitometric analysis was
performed using the Scion Imaging software (Scion
Corporation), using β-actin as a control for each sample.
Flow cytometry
HCT-116 cells were seeded on top of stromal fibroblast
ECM, fibronectin, laminin or collagen type I and detached
with 0.025% EDTA in PBS. For each sample, 106 cells were
used. The cells were washed with PBS and fixed with
2% paraformaldehyde in PBS for 30 min. Staining was
performed by incubating cells with primary antibody
against the extracellular domain of human syndecan-2
(1:100 dilution; Santa Cruz Biotechnology) for 2 h,
followed by incubation with anti-IgG conjugated to Alexa
488 (1:300 dilution, Invitrogen) for 40 min. Data were col-
lected using the FACSCalibur flow cytometer (Becton
Dickinson, CA, USA).
Immunocytochemistry
For immunocytochemical staining, cells were washed with
PBS, fixed with paraformaldehyde for 30 min and blocked
with 5% FBS. The cells were then incubated for 2 h with
the following primary antibodies: rabbit polyclonal anti-
human syndecan-2 (1:100 Santa Cruz Biotechnology)
or goat polyclonal anti-fibronectin (1:100 Santa Cruz
Biotechnology). After washing with PBS, the sections were
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secondary antibody: anti-rabbit IgG or anti-goat IgG, all
produced in donkeys and conjugated to Alexa 594 or Alexa
488 (1:200 Invitrogen). The cells were then counterstained
with a second set of primary and secondary antibodies.
Nuclei were stained using DAPI (0.5 μg/ml, Molecular
Probes, Carlsbad, CA). The cells were mounted using
Fluoromount G (2:1 in PBS, Electron Microscopy Sciences,
Hatfield, PA) and analyzed using a Zeiss LSM510 scanning
confocal inverted microscope (Jena, Germany). Co-
localization images were generated using ImageJ software
(http://rsb.info.nih.gov/ij/) or Zeiss LSM Image Browser.
Cell adhesion assay
Twenty-four-well plates were coated with stromal fibroblast
ECM as described above. HCT-116 cells, previously grown
on top of fibroblast ECM for three days, were detached
with 0.02% trypsin-0.2-mM EDTA, centrifuged and pre-
incubated with anti-syndecan-2 (1:100 Santa Cruz Biotech-
nology), human IgG (1:100 Jackson ImmunoResearch) or
no antibodies for 1 h at 37°C in a 5% CO2 atmosphere. The
cells were then seeded on stromal ECM at a concentration
of 2×105 cells/ml medium and cultured for different lengths
of time. Actin filaments were stained with Alexa 488-
conjugated phalloidin and visualized under a fluores-
cence microscope. The number of adherent cells
was measured by the MTT colorimetric assay. Medium
(200 μl) containing 0.5-mg/ml MTT (Sigma) was added to
each plate, and cells were incubated for 2 h. The medium
was then removed, and 200 μl of dimethyl sulfoxide was
added to each well for 30 min at room temperature. The
mean absorbance at 540 nm in each set of samples
was measured in duplicate using a 96-well microtiter
plate reader.
Cell migration assay
Transwell membranes (Costar, Corning, 8-μm pore size)
were coated with stromal fibroblast ECM as described
above. HCT-116 cells, previously grown on top of fibro-
blast ECM for three days, were detached with 0.02%
trypsin-0.2-mM EDTA, centrifuged and pre-incubated
with anti-syndecan-2 (1:100 Santa Cruz Biotechnology),
human IgG (1:100 Jackson ImmunoResearch) or no anti-
bodies for 1 h at 37°C in a 5% CO2 atmosphere. 2×10
4
HCT-116 cells were plated in 200 μl of RPMI medium in
the top of chamber. In the bottom chamber, 500 μl of
RPMI supplemented with 10% FBS was added. Migration
assays were carried out for 24 h in the tissue culture incu-
bator. The cells were fixed by replacing the culture
medium in both bottom and top chambers with 4% for-
maldehyde dissolved in PBS. After fixation for 15 min at
room temperature, the chambers were rinsed in PBS and
stained with 0.2% crystal violet for 10 min. After the
chambers were washed five times by dipping in a largebeaker of dH2O, cells (now blue in color) in the upper
chamber were removed with several Q-tips. Remaining
cells were counted using an inverted microscope equipped
with a 10X objective and plotted as the percentage of
migratory cells.
Statistical analysis
Statistical significance was determined by paired t test on
Microsoft Excel (Redmond, WA, USA). All experiments
were performed in triplicate unless stated otherwise.
Reproducible results were obtained and representative data
are shown. p-values < 0.05 were considered significant.
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